Botulinum Toxin Injection in the UES for R-CPD

Clinical trial NCT06356025 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06356025
Sponsor: AZ Delta
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Retrograde Cricopharyngeus Dysfunction

Start date: 2024-09-02
Primary completion: 2025-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.